Grants and Contributions:
Title:
Developing a Synthetic Biology Platform for synthesizing new PHA bacteria and metabolic pathways
Agreement Number:
935140
Agreement Value:
$250,000.00
Agreement Date:
Sep 1, 2019 - Mar 19, 2021
Description:
Developing computational tools to create our 2nd generation synthetic PHA bacteria with greater efficiency.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Scarborough, Ontario, CA M1E 2K4
Reference Number:
172-2019-2020-Q2-935140
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
748226693
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 78 days.
Amendment Date
Jan 21, 2021
Recipient's Legal Name:
Genecis Bioindustries Inc.
Federal Riding Name:
Scarborough--Rouge Park
Federal Riding Number:
35097
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
54171
Amendments: